Robert S. Stern, MD

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center
Phone: (617) 667-4995
Fax: (617) 667-4948

rstern@bidmc.harvard.edu

Beth Israel Deaconess Medical Center
Phone: (617) 667-4995
Fax: (617) 667-4948

rstern@bidmc.harvard.edu

Robert S. Stern, MD

Beth Israel Deaconess Medical Center

EDUCATIONAL TITLES

Carl J. Herzog Professor of Dermatologly, Dermatology, Harvard Medical School
Chairman, Dermatology, Beth Israel Deaconess Medical Center

DF/HCC PROGRAM AFFILIATION

Melanoma, Member

Research Abstract

My clinical research interests include the epidemiology of both melanoma and non-melanoma skin cancer and the treatment of skin cancer, particularly non-melanoma skin cancer. I am also involved in the treatment of cutaneous T-cell lymphoma and its precursors. In addition, I participate in teaching and patient care related to the above topics.

Wu PA, Stern RS, Huang V, Liu KX, Chen CA, Tzachanis D, Joyce RM, Davis RB, Ho VT. Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation. J Invest Dermatol 2018. PubMed
Xia FD, Ferket BS, Huang V, Stern RS, Wu PA. Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States. J Am Acad Dermatol 2018. PubMed
Stern RS, Divito SJ. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done. J Invest Dermatol 2017; 137:1004-1008. PubMed
Wu PA, Chen CA, Stern RS. Presence of Hand Warts Is Associated with Subsequent Development of Cutaneous Squamous Cell Carcinoma in Psoriasis Patients Treated with Psoralen UVA (PUVA). J Invest Dermatol 2016. PubMed
Wu PA, Stern RS. How likely is another nonmelanoma skin cancer?: better informing patients and clinicians. JAMA Dermatol 2015; 151:369-70. PubMed
Stern RS. Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis. JAMA 2014; 312:1590-1. PubMed
Stern RS. Cost effectiveness of Mohs micrographic surgery. J Invest Dermatol 2013; 133:1129-31. PubMed
Roujeau JC, Mockenhaupt M, Tahan SR, Henshaw J, Martin EC, Harding M, van Baelen B, Bengtsson L, Singhal P, Kauffman RS, Stern RS. Telaprevir-Related Dermatitis. Arch Dermatol 2012. PubMed
Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 2011. PubMed
Stern RS. Poor metrics and lost opportunity. J Am Acad Dermatol 2010; 63:718-9. PubMed
Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010; 146:279-82. PubMed

Stern RS. Putting Iatrogenic Risk in Perspective: Basal Cell Cancer in PUVA Patients and Australians. J Invest Dermatol 2009; 129:2315-6. PubMed
Nijsten T,Spuls P,Stern RS. STROBE: a Beacon for observational studies. Arch Dermatol 2008; 144:1200-4. PubMed
Martin DC, Atmuri V, Hemming RJ, Farley J, Mort JS, Byers S, Hombach-Klonisch S, Stern R, Triggs-Raine BL. A mouse model of human Mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet 2008; 17:1904-15. PubMed
Hubbard EJ, Santini V, Blankevoort CG, Volkers KM, Barrup MS, Byerly L, Chaisson C, Jefferson AL, Kaplan E, Green RC, Stern RA. Clock drawing performance in cognitively normal elderly. Arch Clin Neuropsychol 2008; 23:295-327. PubMed
Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol 2008; 26:106-22. PubMed
Ashendorf L, Jefferson AL, O'Connor MK, Chaisson C, Green RC, Stern RA. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Arch Clin Neuropsychol 2008; 23:129-37. PubMed
Posternak M, Novak S, Stern R, Hennessey J, Joffe R, Prange A Jr, Zimmerman M. A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response. Int J Neuropsychopharmacol 2008; 11:15-25. PubMed
Stern RS. Chronic medication use and inflammatory skin diseases: the power and limitations of the case-control study. J Invest Dermatol 2007; 127:2709-10. PubMed
Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O, Dix LP, Twomey JA, Stern RS. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2007; 8:1661-91. PubMed
Karagas MR, Stukel TA, Umland V, Tsoukas MM, Mott LA, Sorensen HT, Jensen AO, Nelson HH, Spencer SK, Perry AE, Stern RS. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol 2007; 127:2901-3. PubMed
Stern R, Kogan G, Jedrzejas MJ, Soltes L. The many ways to cleave hyaluronan. Biotechnol Adv 2007; 25:537-57. PubMed
Nijsten T, Looman CW, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 2007; 143:1113-21. PubMed
Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 2007; 357:682-90. PubMed
Malanos D, Stern RS. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study. J Am Acad Dermatol 2007; 57:231-7. PubMed
Jones-Caballero M, Unaeze J, Penas PF, Stern RS. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective. Arch Dermatol 2007; 143:846-50. PubMed

Hide

Robert S. Stern, MD

Beth Israel Deaconess Medical Center

Similar Members

Similar Members

Robert S. Stern, MD

Beth Israel Deaconess Medical Center

EDUCATIONAL TITLES

DF/HCC PROGRAM AFFILIATION

Research Abstract

Publications from Harvard Catalyst Profiles

Similar Members

Similar Members